{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:34:29Z","timestamp":1793684069392,"version":"4.5.1"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.expneurol.2025.115580","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:27:50Z","timestamp":1764894470000},"page":"115580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring the roles of AKR1C1, AKR1C2, and AKR1C3 in the nervous system: Mechanisms and perspectives"],"prefix":"10.1016","volume":"397","author":[{"given":"Xinyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115580_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150218","article-title":"GABAergic implications in anxiety and related disorders","volume":"724","author":"Arora","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2025.115580_bb0010","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3390\/ijms22084053","article-title":"Quantification of dendritic spines remodeling under physiological stimuli and in pathological conditions","volume":"22","author":"B\u0105czy\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41398-021-01266-1","article-title":"Neurosteroid allopregnanolone (3\u03b1,5\u03b1-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors","volume":"11","author":"Balan","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115580_bb0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/antiox10111695","article-title":"The blood\u2013brain barrier, oxidative stress, and insulin resistance","volume":"10","author":"Banks","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.expneurol.2025.115580_bb0030","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/med.21458","article-title":"Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: a literature review","volume":"38","author":"Bansal","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0035","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.neuron.2024.05.003","article-title":"Nuclear aggregates of NONO\/SFPQ and A-to-I-edited RNA in Parkinson&#x2019;s disease and dementia with Lewy bodies","volume":"112","author":"Belur","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2025.115580_bb0040","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/biom13101496","article-title":"Extra-synaptic GABAA receptor potentiation and neurosteroid-induced learning deficits are inhibited by GR3027, a GABAA modulating steroid antagonist","volume":"13","author":"Bengtsson","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2025.115580_bb0045","doi-asserted-by":"crossref","DOI":"10.4103\/crst.crst_250_23","article-title":"Glioblastoma multiforme - a rare type of cancer: a narrative review","volume":"7","author":"Bijalwan","year":"2024","journal-title":"Cancer Res. Stat. Treat."},{"key":"10.1016\/j.expneurol.2025.115580_bb0050","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/febs.16065","article-title":"Long-term plasticity in the hippocampus: maintaining within and \u2018tagging\u2019 between synapses","volume":"289","author":"Bin Ibrahim","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2025.115580_bb0055","first-page":"67","article-title":"The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis","volume":"662","author":"Birtwistle","year":"2009","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.expneurol.2025.115580_bb0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/jc.2004-0583","article-title":"Expression and activity of 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1) in abdominal subcutaneous and omental adipose tissue in women","volume":"90","author":"Blanchette","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"721\u2013737","key":"10.1016\/j.expneurol.2025.115580_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.mp.4001395","article-title":"GABAergic dysfunction in mood disorders","volume":"8","author":"Brambilla","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115580_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2024.102841","article-title":"Cell biology of Parkinson\u2019s disease: mechanisms of synaptic, lysosomal, and mitochondrial dysfunction","volume":"85","author":"Brooker","year":"2024","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2010.11.004","article-title":"Inhibitors of type 5 17\u03b2-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights","volume":"125","author":"Byrns","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2025.115580_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2025.115580_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.expneurol.2025.115580_bb0095","article-title":"Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer&#x2019;s disease","volume":"5","author":"Cheng","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.expneurol.2025.115580_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neures.2024.10.006","article-title":"Neurexin1 level in Huntington\u2019s disease and decreased Neurexin1 in disease progression","volume":"212","author":"Cho","year":"2025","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2025.115580_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109746","article-title":"Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): functions, regulation, and structural insights of inhibitors","volume":"351","author":"Chu","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.expneurol.2025.115580_bb0110","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/ijms24031873","article-title":"Germline mutations in steroid metabolizing enzymes: a focus on steroid transforming aldo-keto reductases","volume":"24","author":"Detlefsen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400601121","article-title":"Progesterone inactivation in decidual stromal cells: a mechanism for inflammation-induced parturition","volume":"121","author":"DeTomaso","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12996","article-title":"Allopregnanolone: an overview on its synthesis and effects","volume":"34","author":"Diviccaro","year":"2022","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0125","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1021\/acsptsci.4c00457","article-title":"Demystifying the role of neuroinflammatory mediators as biomarkers for diagnosis, prognosis, and treatment of Alzheimer\u2019s disease: a review","volume":"7","author":"Doke","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.freeradbiomed.2025.02.005","article-title":"Skin sensitizers enhance superoxide formation by polycyclic aromatic hydrocarbons via the aldo-keto reductase pathway","volume":"230","author":"Eberle","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2025.115580_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2010.10.006","article-title":"Inhibitors of human 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1)","volume":"125","author":"El-Kabbani","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106113","article-title":"Porcine aldo-keto reductase 1C subfamily members AKR1C1 and AKR1C4: substrate specificity, inhibitor sensitivity and activators","volume":"221","author":"Endo","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mds.30114","article-title":"Rigidity in Parkinson\u2019s disease: the objective effect of levodopa","volume":"40","author":"Falletti","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2025.115580_bb0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10142-025-01727-6","article-title":"Integrated multi-omics analysis reveals AKR1C1 as a key mediator of intervertebral disc degeneration: protecting against ferroptosis via PI3K\/AKT signaling","volume":"25","author":"Feng","year":"2025","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.expneurol.2025.115580_bb0155","doi-asserted-by":"crossref","first-page":"1434945","DOI":"10.3389\/fnins.2024.1434945","article-title":"Modeling Alzheimer\u2019s disease using human cell derived brain organoids and 3D models","volume":"18","author":"Fernandes","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0160","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2023.0002","article-title":"NADPH oxidases in neurodegenerative disorders: mechanisms and therapeutic opportunities","volume":"41","author":"Fiadeiro","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2025.115580_bb0165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/15548627.2020.1728096","article-title":"Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease","volume":"17","author":"Franco-Iborra","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115580_bb0170","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1158\/1078-0432.CCR-05-1830","article-title":"In vitro drug response and molecular markers associated with drug resistance in malignant gliomas","volume":"12","author":"Fruehauf","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2025.115580_bb0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/metabo11060343","article-title":"Pleiotropic actions of aldehyde reductase (AKR1A)","volume":"11","author":"Fujii","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.expneurol.2025.115580_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fnins.2011.00131","article-title":"Neurosteroids and GABA(A) receptor interactions: a focus on stress","volume":"5","author":"Gunn","year":"2011","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0185","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.trecan.2024.09.007","article-title":"Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implications","volume":"10","author":"Haase","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.expneurol.2025.115580_bb0190","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11060-025-05011-2","article-title":"The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database","volume":"173","author":"Horowitz","year":"2025","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0195","article-title":"Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants","volume":"6","author":"Houldsworth","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.expneurol.2025.115580_bb0200","first-page":"7","article-title":"Radioactive tracing of testosterone reveals minimal formation of 5\u03b1-DHT in SGBS cells and human primary adipocytes","volume":"9","author":"Huacachino","year":"2025","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.expneurol.2025.115580_bb0205","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/srep01528","article-title":"Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer","volume":"3","author":"Ishizaki","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115580_bb0210","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3390\/molecules27217149","article-title":"Anxiolytic-like effect of quercetin possibly through GABA receptor interaction pathway: in vivo and in silico studies","volume":"27","author":"Islam","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.expneurol.2025.115580_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00702-024-02744-8","article-title":"Mild cognitive impairment in Huntington\u2019s disease: challenges and outlooks","volume":"131","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2025.115580_bb0220","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00702-024-02750-w","article-title":"The pathobiology of depression in Huntington\u2019s disease: an unresolved puzzle","volume":"131","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2025.115580_bb0225","doi-asserted-by":"crossref","first-page":"13054","DOI":"10.1021\/bi060591r","article-title":"Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens","volume":"45","author":"Jin","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2025.115580_bb0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/BJ20101804","article-title":"Stereospecific reduction of 5\u03b2-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5\u03b2-reductase pathway","volume":"437","author":"Jin","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2025.115580_bb0235","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1038\/s41598-025-92866-0","article-title":"Dynamic change of estrogen and progesterone metabolites in human urine during pregnancy","volume":"15","author":"Jin","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115580_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1173433","article-title":"Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through","volume":"16","author":"Jusop","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0245","doi-asserted-by":"crossref","first-page":"12299","DOI":"10.3390\/ijms252212299","article-title":"Molecular roles of NADPH oxidase-mediated oxidative stress in Alzheimer\u2019s disease: isoform-specific contributions","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0250","article-title":"Molecular roles of NADPH oxidase-mediated oxidative stress in Alzheimer\u2019s disease: isoform-specific contributions","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/appi.ajp.2020.20020134","article-title":"Understanding the clinical effects and mechanisms of action of neurosteroids","volume":"178","author":"Kleinman","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115580_bb0260","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.7150\/thno.100327","article-title":"Activation of toll-like receptor 2 promotes mesenchymal stem\/stromal cell-mediated immunoregulation and angiostasis through AKR1C1","volume":"14","author":"Ko","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.expneurol.2025.115580_bb0265","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41583-023-00724-7","article-title":"GABA tone regulation and its cognitive functions in the brain","volume":"24","author":"Koh","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0270","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1152\/physrev.00034.2023","article-title":"NADPH oxidases: redox regulation of cell homeostasis and disease","volume":"105","author":"Kra\u010dun","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2013.11.036","article-title":"Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats","volume":"723","author":"Kumar","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0280","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1038\/s41467-024-49298-7","article-title":"G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells","volume":"15","author":"Kyrkou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2025.115580_bb0285","first-page":"3","article-title":"Enzymes of the AKR1B and AKR1C subfamilies and uterine diseases","author":"Lanisnik Rizner","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0290","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1593\/neo.10526","article-title":"Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression","volume":"12","author":"Le Calv\u00e9","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.expneurol.2025.115580_bb0295","first-page":"83","article-title":"Classic and backdoor pathways of androgen biosynthesis in human sexual development","volume":"27","author":"Lee","year":"2022","journal-title":"Apem"},{"key":"10.1016\/j.expneurol.2025.115580_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101878","article-title":"lncRNA NEAT1: key player in neurodegenerative diseases","volume":"86","author":"Li","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0305","first-page":"2233906","article-title":"Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): implications in the pathogenesis and treatment of aging-related diseases","volume":"2022","author":"Li","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.expneurol.2025.115580_bb0310","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.3390\/ijms25105169","article-title":"Advances in therapeutics to alleviate cognitive decline and neuropsychiatric symptoms of Alzheimer\u2019s disease","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0315","first-page":"15","article-title":"AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100925","article-title":"Neurosteroidogenic enzymes: CYP11A1 in the central nervous system","volume":"62","author":"Lin","year":"2021","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0325","article-title":"Comprehensive analysis regarding the prognostic significance of downregulated ferroptosis-related gene AKR1C2 in gastric cancer and its underlying roles in immune response","volume":"18","author":"Liu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2025.115580_bb0330","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41418-024-01407-1","article-title":"The AKR1C1\u2013CYP1B1\u2013cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma","volume":"32","author":"Liu","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2025.115580_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102210","article-title":"Implication of type 4 NADPH oxidase (NOX4) in tauopathy","volume":"49","author":"Luengo","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0340","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","article-title":"GABAA receptors as targets for treating affective and cognitive symptoms of depression","volume":"44","author":"Luscher","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0345","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.3390\/cancers14246210","article-title":"Progestin resistance and corresponding management of abnormal endometrial hyperplasia and endometrial carcinoma","volume":"14","author":"Lv","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.expneurol.2025.115580_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuint.2012.10.007","article-title":"Aldo\u2013keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells","volume":"62","author":"Lyon","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2025.115580_bb0355","doi-asserted-by":"crossref","first-page":"2100256","DOI":"10.1002\/minf.202100256","article-title":"Investigation of the potential of bile acid methyl esters as inhibitors of aldo-keto reductase 1C2: insight from molecular docking, virtual screening, experimental assays and molecular dynamics","volume":"41","author":"Marinovi\u0107","year":"2022","journal-title":"Mol. Inf."},{"key":"10.1016\/j.expneurol.2025.115580_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103263","article-title":"Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis","volume":"147","author":"Martin","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2025.115580_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00525","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: guiding the path to targeted therapies","volume":"22","author":"McGill Percy","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2025.115580_bb0370","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2007.04.011","article-title":"Neurosteroid regulation of central nervous system development","volume":"116","author":"Mellon","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2025.115580_bb0375","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41531-024-00818-8","article-title":"Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson\u2019s disease","volume":"10","author":"Mendon\u00e7a","year":"2024","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.expneurol.2025.115580_bb0380","article-title":"Human aldo-keto reductase (AKR) 1C1 and 1C2 act as coactivators of pregnane X receptor, a master regulator of drug-metabolizing and gluconeogenesis enzymes","volume":"101481","author":"Mitamura","year":"2025","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.expneurol.2025.115580_bb0385","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/biom14040460","article-title":"Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors of the mouse nucleus accumbens","volume":"14","author":"Mitchell","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2025.115580_bb0390","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.32604\/or.2024.049918","article-title":"Aldo-keto reductases: role in cancer development and theranostics","volume":"32","author":"Nagini","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.expneurol.2025.115580_bb0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14730\/aaps.2016.22.1.35","article-title":"Expression of AKR1C3 protein in human keloid skin tissue","volume":"22","author":"Nam","year":"2016","journal-title":"Arch. Aesthet. Plast. Surg."},{"key":"10.1016\/j.expneurol.2025.115580_bb0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","article-title":"Diffuse glioma heterogeneity and its therapeutic implications","volume":"11","author":"Nicholson","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.expneurol.2025.115580_bb0405","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1186\/s12967-023-04711-5","article-title":"Long read sequencing characterises a novel structural variant, revealing underactive AKR1C1 with overactive AKR1C2 as a possible cause of severe chronic fatigue","volume":"21","author":"Oakley","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.expneurol.2025.115580_bb0410","doi-asserted-by":"crossref","first-page":"9689","DOI":"10.3390\/ijms25179689","article-title":"Alzheimer\u2019s disease as a membrane dysfunction tauopathy? New insights into the amyloid cascade hypothesis","volume":"25","author":"Olejar","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0415","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/antiox12020517","article-title":"Oxidative stress and antioxidants in neurodegenerative disorders","volume":"12","author":"Olufunmilayo","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.expneurol.2025.115580_bb0420","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/cimb46030153","article-title":"Deciphering glioblastoma: fundamental and novel insights into the biology and therapeutic strategies of gliomas","volume":"46","author":"Onciul","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0425","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/jpm12091485","article-title":"iPSCs in neurodegenerative disorders: a unique platform for clinical research and personalized medicine","volume":"12","author":"Pandey","year":"2022","journal-title":"J. Personal. Med."},{"key":"10.1016\/j.expneurol.2025.115580_bb0430","first-page":"743","article-title":"Differential expression of type 2 3\u03b1\/type 5 17\u03b2-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system","volume":"3","author":"Park","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0435","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/acs.chemrestox.6b00319","article-title":"Aldo-keto reductase regulation by the Nrf2 system: implications for stress response, chemotherapy drug resistance, and carcinogenesis","volume":"30","author":"Penning","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0440","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2018.07.002","article-title":"AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): roles in malignancy and endocrine disorders","volume":"489","author":"Penning","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2009.03700.x","article-title":"Steroid hormone transforming aldo-keto reductases and cancer","volume":"1155","author":"Penning","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0450","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2009.03700.x","article-title":"Steroid hormone transforming aldo-keto reductases and cancer","volume":"1155","author":"Penning","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0455","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.3390\/ijms25168857","article-title":"5\u03b2-dihydrosteroids: formation and properties","volume":"25","author":"Penning","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0460","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0303-7207(00)00426-3","article-title":"Structure-function aspects and inhibitor design of type 5 17\u03b2-hydroxysteroid dehydrogenase (AKR1C3)","volume":"171","author":"Penning","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0465","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0470","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0475","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0480","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/B:NERE.0000018843.83770.4b","article-title":"Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington\u2019s disease mutation","volume":"29","author":"P\u00e9rez-Severiano","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2025.115580_bb0485","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0490","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-3-031-36159-3_4","article-title":"Dendritic spines: synaptogenesis and synaptic pruning for the developmental organization of brain circuits","volume":"34","author":"Petanjek","year":"2023","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40263-024-01128-6","article-title":"The role of GABA receptors in anesthesia and sedation: an updated review","volume":"39","author":"Philip","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.expneurol.2025.115580_bb0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson\u2019s disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.expneurol.2025.115580_bb0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0510","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/biom14010073","article-title":"Advancements in genetic and biochemical insights: unraveling the etiopathogenesis of neurodegeneration in Parkinson\u2019s disease","volume":"14","author":"Ratan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2025.115580_bb0515","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13034","article-title":"New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type-1 cannabinoid receptor (CB1R) activity and function","volume":"34","author":"Raux","year":"2022","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0520","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.123.001816","article-title":"Neurosteroids as novel anticonvulsants for refractory status epilepticus and medical countermeasures for nerve agents: a 15-year journey to bring ganaxolone from bench to clinic","volume":"388","author":"Reddy","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2025.115580_bb0525","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1210\/en.2002-0032","article-title":"Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells","volume":"144","author":"Rizner","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2025.115580_bb0530","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1210\/en.2002-0032","article-title":"Human type 3 3\u03b1-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells","volume":"144","author":"Ri\u017ener","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2025.115580_bb0535","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/diagnostics15050538","article-title":"Malignant meningiomas: from diagnostics to treatment","volume":"15","author":"Rowbottom","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.expneurol.2025.115580_bb0540","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41420-024-01974-9","article-title":"New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity","volume":"10","author":"Ruan","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2025.115580_bb0545","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00406-022-01532-3","article-title":"Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options","volume":"273","author":"Rupprecht","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105356","article-title":"Neurosteroids and the mesocorticolimbic system","volume":"153","author":"Seib","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2025.115580_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318079","article-title":"Aldo-keto reductase family 1 member C3 (AKR1C3) gene polymorphism (rs12529) is associated with breast cancer in Bangladeshi population: a case-control study and computational investigation","volume":"20","author":"Shaon","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2025.115580_bb0560","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/biom14121649","article-title":"Alpha-synuclein effects on mitochondrial quality control in Parkinson\u2019s disease","volume":"14","author":"Shen","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2025.115580_bb0565","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cbi.2014.11.009","article-title":"Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2\u03b1 biosynthesis and action in ovarian endometriosis tissue and in model cell lines","volume":"234","author":"Sinreih","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.expneurol.2025.115580_bb0570","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1080\/14756366.2021.1937142","article-title":"Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives","volume":"36","author":"Sinreih","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.expneurol.2025.115580_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109542","article-title":"Neurosteroids as positive and negative allosteric modulators of ligand-gated ion channels: P2X receptor perspective","volume":"234","author":"Sivcev","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2025.115580_bb0580","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00294.2021","article-title":"Gut feelings: the microbiota-gut-brain axis on steroids","volume":"322","author":"So","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0585","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/ijms21103592","article-title":"Mitochondrial function in modulating human granulosa cell steroidogenesis and female fertility","volume":"21","author":"Sreerangaraja Urs","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246193","article-title":"Synaptic plasticity shapes brain connectivity: implications for network topology","volume":"20","author":"Stampanoni Bassi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2024.109427","article-title":"Metabolism of progestogens used for contraception and menopausal hormone therapy","volume":"207","author":"Stanczyk","year":"2024","journal-title":"Steroids"},{"key":"10.1016\/j.expneurol.2025.115580_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15020132","article-title":"Natural source of drugs targeting central nervous system tumors-focus on NAD(P)H oxidoreductase 1 (NQO1) activity","volume":"15","author":"Stojanovic","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0605","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/ijms24010507","article-title":"Modulation of muscarinic signalling in the central nervous system by steroid hormones and neurosteroids","volume":"24","author":"Szczurowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0610","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1593\/neo.05715","article-title":"The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas","volume":"8","author":"Tabori","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.expneurol.2025.115580_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111477","article-title":"GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generation","volume":"124","author":"Tang","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.expneurol.2025.115580_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2025.123821","article-title":"A population-based cohort study of glioblastoma (World Health Organization grade 4 gliomas) in Ontario: continued improvement in care over 25 years","volume":"196","author":"Taslimi","year":"2025","journal-title":"World Neurosurg."},{"key":"10.1016\/j.expneurol.2025.115580_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100976","article-title":"Neuropeptidergic control of neurosteroids biosynthesis","volume":"65","author":"Ubuka","year":"2022","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0630","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/neuonc\/noae213","article-title":"Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection\u2014update 1","volume":"27","author":"van den Bent","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.expneurol.2025.115580_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105527","article-title":"Role of human 3\u03b1-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator Formestane","volume":"198","author":"Wan","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0640","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","article-title":"Lactobacillus plantarum DP189 reduces \u03b1-SYN aggravation in MPTP-induced Parkinson\u2019s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder","volume":"70","author":"Wang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.expneurol.2025.115580_bb0645","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1038\/s41467-024-47683-w","article-title":"Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer\u2019s disease mouse models","volume":"15","author":"Was\u00e9n","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2025.115580_bb0650","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.expneurol.2025.115580_bb0655","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41398-021-01757-1","article-title":"Sex differences in neuronal systems function and behaviour: beyond a single diagnosis in autism spectrum disorders","volume":"11","author":"Williams","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115580_bb0660","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsbmb.2017.11.006","article-title":"Transition from androgenic to neurosteroidal action of 5\u03b1-androstane-3\u03b1, 17\u03b2-diol through the type a \u03b3-aminobutyric acid receptor in prostate cancer progression","volume":"178","author":"Xia","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0665","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsbmb.2017.11.006","article-title":"Transition from androgenic to neurosteroidal action of 5\u03b1-androstane-3\u03b1, 17\u03b2-diol through the type A \u03b3-aminobutyric acid receptor in prostate cancer progression","volume":"178","author":"Xia","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0670","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/CM9.0000000000001379","article-title":"Roles of <i>AKR1C3<\/i> in malignancy","volume":"134","author":"Xiao","year":"2021","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.expneurol.2025.115580_bb0675","doi-asserted-by":"crossref","first-page":"2401041","DOI":"10.1002\/advs.202401041","article-title":"Proteogenomic landscape of breast ductal carcinoma reveals tumor progression characteristics and therapeutic targets","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0680","doi-asserted-by":"crossref","first-page":"P709","DOI":"10.1016\/j.jalz.2013.05.1401","article-title":"P4\u2013013: Allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease, 3: evidence for potentiation of brain mitochondrial function","volume":"9","author":"Yao","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2025.115580_bb0685","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41583-022-00624-2","article-title":"CaMKII: a central molecular organizer of synaptic plasticity, learning and memory","volume":"23","author":"Yasuda","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115580_bb0690","first-page":"4","article-title":"The activity of SN33638, an inhibitor of AKR1C3, on testosterone and 17\u03b2-estradiol production and function in castration-resistant prostate cancer and ER-positive breast cancer","author":"Yin","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0695","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-015-0189-z","article-title":"Loss of angiotensin II receptor expression in dopamine neurons in Parkinson\u2019s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation","volume":"3","author":"Zawada","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2025.115580_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103086","article-title":"Iron\/ROS\/Itga3 mediated accelerated depletion of hippocampal neural stem cell pool contributes to cognitive impairment after hemorrhagic stroke","volume":"71","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176699","article-title":"Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling","volume":"976","author":"Zhang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0710","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.3390\/cancers13102403","article-title":"Aldo-keto reductase 1C3 mediates chemotherapy resistance in esophageal adenocarcinoma via ROS detoxification","volume":"13","author":"Zhou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.expneurol.2025.115580_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.590861","article-title":"Clinical and biological significances of a ferroptosis-related gene signature in glioma","volume":"10","author":"Zhuo","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.expneurol.2025.115580_bb0720","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.3390\/cancers16172976","article-title":"Analysis of expression and regulation of AKR1C2 in HPV-positive and -negative oropharyngeal squamous cell carcinoma","volume":"16","author":"Ziogas","year":"2024","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.expneurol.2025.115580_bb0725","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.63.10.3","article-title":"AKR1C1 protects corneal epithelial cells against oxidative stress-mediated ferroptosis in dry eye","volume":"63","author":"Zuo","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625004455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625004455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:27:41Z","timestamp":1781270861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625004455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":145,"alternative-id":["S0014488625004455"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115580","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the roles of AKR1C1, AKR1C2, and AKR1C3 in the nervous system: Mechanisms and perspectives","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115580"}}